Skip to main content

Advertisement

Log in

Idiopathic Myelofibrosis in an Infant

  • Clinical Brief
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Idiopathic Myelofibrosis (MF) is an extremely rare condition in children. It has a very variable clinical spectrum. Cases of secondary myelofibrosis associated with Vitamin D deficiency and Systemic Lupus Erythematosus have been reported from India .In this case report, the authors describe clinical signs, laboratory findings and histologic features in a 6 month old infant with Idiopathic myelofibrosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Johnston J Martin. Myelofibrosis. Available from URL: http://www.emedicine.medscape.com/article/956806-overview. Accessed May 15 2009.

  2. Naithani R, Tyagi S, Choudhry VP. Secondary myelofibrosis in children. J Pediatr Hematol Oncol. 2008;30:196–8.

    Article  PubMed  Google Scholar 

  3. Chandra J, Narayan S, Kumar P, et al. Myelofibrosis. Indian Pediatr. 1992;29:911–4.

    PubMed  CAS  Google Scholar 

  4. Rani S, Maheshwari C, Singh T. Beohar PC.Idiopathic myelofibrosis. Indian Pediatr. 1984;21:817–20.

    PubMed  CAS  Google Scholar 

  5. Narayan S, Chandra J, Sharma S, Aiyer H. Idiopathic Myelofibrosis in children. Indian JHemat and Blood Trans. 2000;18:100–1.

    Google Scholar 

  6. Bain BJ,Clark DM,Lampert IA,Wilkins BS. Myeloproliferative disorders.In Bain BJ,Clark DM,Lampert IA,Wilkins BS eds.Bone Marrow athology.Oxford,Blackwell Science,2000;202–208

  7. Komura E, Tonetti C, Penard-Lacronique V. Role for the nuclear factor kappaB pathway in transforming growth factor-beta1 production in idiopathic myelofibrosis: possible relationship with FK506 binding protein 51 overexpression. Cancer Res. 2005;65:3281–9.

    PubMed  CAS  Google Scholar 

  8. Stephan JL, Galambrun C, Dutour A. Myelofibrosis: an unusual presentation of vitamin D-deficient rickets. Eur J Pediatr. 1999;158:828–9.

    Article  PubMed  CAS  Google Scholar 

  9. Wolf BC, Neiman RS. Myelofibrosis with myeloid metaplasia: pathophysiologic implications of the correlation between bone marrow changes and progression of splenomegaly. Blood. 1985;65:803–9.

    PubMed  CAS  Google Scholar 

  10. Agarwal BR, Bhalla K, Dalvi R, Currimbhoy ZE, Mehta KP. Myelofibrosis secondary to SLE and its reversal on steroid therapy. Indian Pediatr. 1995;32:1207–10.

    PubMed  CAS  Google Scholar 

  11. Kerbauy DM, Gooley TA, Sale GE. Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia. Biol Blood Marrow Transplant. 2007;13:355–65.

    Article  PubMed  Google Scholar 

  12. Hasselbalch HC, Bjerrum OW, Jensen BA, et al. Imatinib mesylate in idiopathic and postpolycythemic myelofibrosis. Am J Hematol. 2003;74:238–42.

    Article  PubMed  CAS  Google Scholar 

  13. Mesa RA, Nagorney DS, Schwager S. Palliative goals, patient selection, and perioperative platelet management: outcomes and lessons from 3 decades of splenectomy for myelofibrosis with myeloid metaplasia at the Mayo Clinic. Cancer. 2006;107:361–70.

    Article  PubMed  Google Scholar 

Download references

Conflict of Interest

None.

Role of Funding Source

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rajesh K. Kulkarni.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bavikar, R.R., Kulkarni, R.K., Rathod, A.D. et al. Idiopathic Myelofibrosis in an Infant. Indian J Pediatr 78, 734–736 (2011). https://doi.org/10.1007/s12098-010-0340-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-010-0340-6

Keywords

Navigation